Could you elaborate on some of the most prominent trends shaping the landscape of clinical trials in the Asia-Pacific re...
Making its triumphant return to the region this Summer, this meeting will bring together key players of the ADC lan...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
What makes Uvax Bio’s technology different from other vaccine technologies? Recombinant protein vaccines ar...
Could you elaborate on the most prominent trends shaping the APAC clinical trials landscape? One of Lokavant’s ea...
While the increasing volume of clinical data is welcome in many respects, clinicians and trial managers often struggle w...
Over the past decade, the Asia-Pacific (APAC) region has emerged as a global leader in clinical trial conduct. In 2021, ...
The APAC region continues to rule the roost in clinical trials, experiencing dramatic growth rates surpassing those in t...
Australian Translational Genomics Centre (ATGC) at Queensland University of Technology (QUT) will help link Queensland...
A team of healthcare professionals has received a $50,000 award to transform their idea for an Artificial Intelligence (...
ClinChoice, a global Contract Research Organisation (CRO), has announced expanding its global footprint with the acquisi...
The Coalition for Epidemic Preparedness Innovations (CEPI), the Republic of Korea-based International Vaccine Institute ...
US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration ...
An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as...
According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
